Company intelligence / Profile preview

Alfatest

Cernusco sul Naviglio, MI, Italyalfatestlab.com ↗

Ownership: Private
Development stage: Other

Overview

Alfatest, through its contract analysis division AlfatestLAB, provides ISO 17025-accredited and GMP-certified analytical and characterization services supporting pharmaceutical and biopharmaceutical product development, quality control, and in‑vitro bioequivalence studies rather than developing its own therapeutic pipeline.[2][3][7]

Modalities: Small moleculeBiologicNanoparticleVaccineProteinPeptidesCell therapyRNA therapy
Industry: Drug Discovery Services

Partnerships

Malvern PanalyticalThermo ScientificMicromeritics

Beyond the preview

Go deeper on Alfatest.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alfatest.

Explore the full profile